Physician profile
Irlene Locklear
NPI 1609946607
$735.68
in general payments reported to CMS, 2019-2025
18 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.73 · 2020: $117 · 2021: $212 · 2022: $97.04 · 2023: $107 · 2024: $66.16 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $125.01 | 2025 | Opsumit, Uptravi |
| Medtronic, INC. | $112.39 | 2023-2024 | Illumisite |
| Chiesi USA, INC. | $96.15 | 2020-2022 | |
| Veran Medical Technologies, INC. | $95.98 | 2020-2021 | |
| Pulmonx Corporation | $74.40 | 2021 | |
| Glaxosmithkline, LLC. | $31.44 | 2020-2023 | Trelegy Ellipta |
| Bioxcel Therapeutics, INC. | $22.70 | 2023 | Igalmi |
| United Therapeutics Corporation | $22.62 | 2023 | Tyvaso |
| Merck Sharp & Dohme LLC | $21.74 | 2022 | |
| Janssen Pharmaceuticals, INC | $20.11 | 2022 | |
| Olympus America INC. | $18.81 | 2021 | |
| Insmed, INC. | $17.35 | 2022 | |
| Livanova USA, INC. | $17.32 | 2021 | |
| Applied Medical Technology INC | $14.09 | 2022 | |
| Acacia Pharma INC | $13.35 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $13.22 | 2021 | |
| Mylan Specialty L.P. | $11.73 | 2019 | |
| Zoll Circulation INC | $7.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irlene Locklear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.